KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502.

Daniel G Stover, Roberto Salgado, Oleksander Savenkov, Karla Ballman, Erica L Mayer, Mark Jesus M Magbanua, Sherene Loi, Mark Vater, Kristyn Glover, Mark Watson, Yujia Wen, W Fraser Symmans, Charles Perou, Lisa A Carey, Ann H Partridge, Hope S Rugo

NPJ Breast Cancer 10(1) 75

PMID39169033
PMCIDPMC11339397
DOI10.1038/s41523-024-00683-x
发表日期2024-08-21
摘要

摘要

Association of stromal tumor-infiltrating lymphocytes (sTILs) with survival outcomes among patients with metastatic breast cancer (MBC) remains unclear. The primary objective was to evaluate the association of sTILs with progression-free survival in randomized phase III trial CALGB 40502. sTILs were associated with progression-free and overall survival in chemotherapy-treated MBC when controlling for treatment arm; however, this effect did not remain significant after additional adjustment for hormone receptor status. CALGB is now part of the Alliance for Clinical Trials in Oncology. Trial Registration: ClinicalTrials.gov: NCT00785291.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。